ASX announcements

Annual General Meeting 2020 - Chair's Address

Virtus Health 2020 Annual Report

Notice of Virtus Health's 2020 Annual General Meeting

Virtus Health provides an update on preimplantation genetic testing

Interim Dividend Payment Confirmed

Notification Of Release Of Restricted Shares From Escrow

Notification of closing date for receipt of director nominations

Financial Results Presentation Full Year 2020

Appendix 4G - 30 June 2020

Appendix 4E Preliminary Final Report - 30 June 2020

Virtus Health Full Year Financial Results FY20 media release

Notification of FY20 Full Year Results - Reporting Date and Investor Conference Call

Virtus Health advises that a total of 68,305 fully paid ordinary shares currently held under voluntary escrow are due for release on 5 June 2020.

Virtus Health is presenting at the UBS Emerging Company Conference today and is pleased to disclose the management presentation

Virtus Health is pleased to confirm it has amended its bank finance facilities through to 30 June 2021.

Virtus supports today’s decision by the Australian Federal Government to lift the suspension on elective surgery, including Assisted Reproductive Services

Virtus Health advises that a total of 377,262 fully paid ordinary shares currently held under voluntary escrow are due for release as follows

Further to the market update on 25 March 2020, Virtus has undertaken a number of initiatives across the group in response to COVID-19

ASX Virtus Health continue to engage with state health departments regarding its private hospital capacity to provide facilities and staff.

Virtus Health Limited (ASX “VRT”) provides the following update on the impact of COVID-19.